3 completed, 2 active not recruiting, 2 withdrawn, 1 recruiting. 4 Phase 1, 2 Phase 2, 1 Early Phase 1, 1 Not applicable, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Active not recruiting 2, Withdrawn 2 |
| Phase 2 | 2 | Completed 1, Recruiting 1 |
| Early Phase 1 | 1 | Completed 1 |
| Not applicable | 1 | Unknown 1 |
| Phase 4 | 1 | Completed 1 |
Follow Malignant Neoplasms of Digestive Organs: new trials by email Literature Review of Malignant Neoplasms of Digestive Organs trials Research Report on Malignant Neoplasms of Digestive Organs
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A LM-302 Combination With Other Anti-Tumor Therapies Phase ll Study LM-302, Toripalimab, Capecitabine - Malignant Neoplasms of Digestive Organs | Phase 2 | Recruiting | LaNova Medicines Zhejiang Co., Ltd. | 632 | 2023-07-27 | 2026-10-19 |
| CART Therapy in Digestive System Tumors gucy2c cart cells - Malignant Neoplasms of Digestive Organs | Not applicable | Unknown | Innovative Cellular Therapeutics Co., Ltd. | 20 | 2021-03-01 | 2021-03-03 |
| CART Therapy in GUCY2C-positive Digestive Tract Tumors gucy2c cart cells - Malignant Neoplasms of Digestive Organs | Early Phase 1 | Completed | Weijia Fang, MD | 1 | 2020-10-10 | 2023-07-17 |
| Pembrolizumab With Intratumoral Injection of Clostridium Novyi-NT Pembrolizumab, Clostridium Novyi-NT, Doxycycline - Malignant Neoplasm of Breast, Malignant Neoplasms of Digestive Organs | Phase 1 | Active not recruiting | M.D. Anderson Cancer Center | 18 | 2018-07-10 | 2026-04-16 |
| Study of Durvalumab (MEDI4736) (Anti-PD-L1) and Trametinib (MEKi) in MSS Metastatic Colon Cancer Durvalumab, Trametinib - Malignant Neoplasms of Digestive Organs, Colorectal Cancer | Phase 2 | Completed | M.D. Anderson Cancer Center | 29 | 2018-03-21 | 2023-06-15 |
| Neuromuscular Blockade on Shoulder Pain of Elderly Deep Neuromuscular Blockade (NMB), Moderate Neuromuscular Blockade (NMB), Sugammadex - Malignant Neoplasms of Digestive Organs, Malignant Neoplasms of Female Genital Organs | Phase 4 | Completed | M.D. Anderson Cancer Center | 100 | 2017-11-17 | 2020-11-25 |
| Selumetinib and Olaparib in Solid Tumors Selumetinib, Olaparib - Malignant Neoplasm of Breast, Malignant Neoplasms of Digestive Organs | Phase 1 | Active not recruiting | M.D. Anderson Cancer Center | 90 | 2017-08-04 | 2026-10-13 |
| Lenvatinib and Capecitabine in Patients With Advanced Malignancies Lenvatinib, Capecitabine - Advanced Cancer, Malignant Neoplasm of Breast | Phase 1 | Withdrawn | M.D. Anderson Cancer Center | 2016-12-01 | 2017-06-26 | |
| Alisertib and TAK-228 in Participants With Human Papilloma Virus (HPV) Associated Malignancies Alisertib, TAK-228 - Malignant Neoplasms of Digestive Organs, Malignant Neoplasms of Female Genital Organs | Phase 1 | Withdrawn | M.D. Anderson Cancer Center | 2016-09-01 | 2017-03-27 |
Breast Neoplasms (3) · Urologic Neoplasms (3) · Colonic Neoplasms (1) · Colorectal Neoplasms (1)
Neoplasms (5) · Neoplasms by Site (5) · Breast Diseases (3) · Female Urogenital Diseases (3) · Female Urogenital Diseases and Pregnancy Complications (3) · Male Urogenital Diseases (3) · Skin Diseases (3) · Skin and Connective Tissue Diseases (3) · Urogenital Diseases (3) · Urogenital Neoplasms (3) · Urologic Diseases (3) · Colonic Diseases (1) · Digestive System Diseases (1) · Digestive System Neoplasms (1) · Gastrointestinal Diseases (1)
Capecitabine (2) · AZD 6244 (1) · Doxycycline (1) · Gemcitabine (1) · MLN 8237 (1) · Neostigmine (1) · Nivolumab (1) · Sugammadex (1) · Surveys and Questionnaires (1) · Tegafur (1) · anlotinib (1) · apatinib (1) · durvalumab (1) · gimeracil (1) · lenvatinib (1)
M.D. Anderson Cancer Center (6) · Innovative Cellular Therapeutics Co., Ltd. (1) · LaNova Medicines Zhejiang Co., Ltd. (1) · Weijia Fang, MD (1)
United States (4) · China (3)
Aiping Zhou (1) · Chunmei Bai (1) · David S. Hong, MD (1) · Deliang Fu (1) · Haijiao Yan (1) · Haiping Jiang (1) · Jieer Ying (1) · Jin Li (1) · Jing Dai (1) · Jun Zhou (1) · Kuirong Jiang (1) · Liang Liu (1) · Lixin Wan (1) · Michael Overman, MD (1) · Mingzhu Huang (1)